LMR Partners’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.6M | Buy |
22,895
+22,545
| +6,441% | +$1.58M | 0.01% | 361 |
|
|
2025
Q1 | $25.7K | Sell |
350
-141,612
| -100% | -$10.4M | ﹤0.01% | 783 |
|
|
2024
Q4 | $9.3M | Buy |
141,962
+126,676
| +829% | +$8.3M | 0.08% | 166 |
|
|
2024
Q3 | $1.19M | Sell |
15,286
-10,600
| -41% | -$826K | 0.01% | 312 |
|
|
2024
Q2 | $2.02M | Sell |
25,886
-243,230
| -90% | -$19M | 0.02% | 254 |
|
|
2024
Q1 | $18.2M | Sell |
269,116
-8,400
| -3% | -$569K | 0.19% | 59 |
|
|
2023
Q4 | $18.7M | Sell |
277,516
-124,600
| -31% | -$8.39M | 0.21% | 68 |
|
|
2023
Q3 | $27.2M | Sell |
402,116
-575,319
| -59% | -$39M | 0.31% | 41 |
|
|
2023
Q2 | $70M | Buy |
977,435
+362,607
| +59% | +$26M | 0.78% | 7 |
|
|
2023
Q1 | $42.7M | Buy |
+614,828
| New | +$42.7M | 0.66% | 23 |
|
|
2021
Q4 | – | Sell |
-271,173
| Closed | -$16.4M | – | 1145 |
|
|
2021
Q3 | $16.4M | Buy |
+271,173
| New | +$16.4M | 0.18% | 106 |
|
|
2021
Q1 | – | Sell |
-126,605
| Closed | -$6.33M | – | 953 |
|
|
2020
Q4 | $6.33M | Sell |
126,605
-19,249
| -13% | -$962K | 0.1% | 92 |
|
|
2020
Q3 | $7.99M | Buy |
145,854
+105,854
| +265% | +$5.8M | 0.16% | 66 |
|
|
2020
Q2 | $2.12M | Buy |
+40,000
| New | +$2.12M | 0.05% | 245 |
|